Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767)

Yuan Hung Kuo, Sheng Nan Lu, Yen Yang Chen, Kwong Ming Kee, Yi Hao Yen, Chao Hung Hung, Tsung Hui Hu, Chien Hung Chen, Jing Houng Wang*

*此作品的通信作者

研究成果: 期刊稿件 › 評論/辯論

10 引文 斯高帕斯（Scopus）

指紋

深入研究「Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767)」主題。共同形成了獨特的指紋。

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Psychology